IRVINE, Calif., October 09, 2023 Immunis, Inc., a private biotech pioneering cellular secretome treatments to address age and disease-related immune decline, is pleased to announce that its Chairman, Dr. Hans Keirstead, will be taking center stage at the prestigious Innovative Therapies Days conference in Besançon, France. Innovative Therapies Days is a premier event in medical innovation, showcasing presentations from esteemed clinicians, scientists, and industry partners. This year, the confe
In his latest research note, analyst Karl Keirstead confirms his recommendation. The broker UBS is keeping its Neutral rating. The target price has been revised upwards and is now set at USD 300,. | April 27, 2023
Presenter SpeechKarl Keirstead All right. Thank you, everybody. Happy to have MongoDB. Mike and Serge worked together, they have for years. They insist their cozies enough with each other, snuggle up. | December 7, 2022